Siemens Healthineers (SMMNY) Projected to Release Quarterly Earnings on Friday

Posted by Hanz Christensen on Jul 29th, 2026

Siemens Healthineers (OTCMKTS:SMMNY – Get Free Report) is anticipated to announce its resultson Friday, July 31st. Analysts expect Siemens Healthineers to announce earnings of $0.3022 per share and revenue of $6.4503 billion for the quarter.

Siemens Healthineers (OTCMKTS:SMMNY – Get Free Report) last released its quarterly earnings results on Thursday, May 7th. The company reported $0.31 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.02. The firm had revenue of $6.68 billion for the quarter, compared to analysts’ expectations of $6.96 billion.

Siemens Healthineers Trading Up 1.3%

Shares of OTCMKTS:SMMNY opened at $20.46 on Wednesday. Siemens Healthineers has a 12 month low of $19.20 and a 12 month high of $28.92. The firm’s 50-day moving average is $19.88 and its 200 day moving average is $21.90.

Analysts Set New Price Targets

Separately, Zacks Research downgraded shares of Siemens Healthineers from a “hold” rating to a “strong sell” rating in a research note on Friday, May 15th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy”.

Get Our Latest Stock Analysis on SMMNY

About Siemens Healthineers

(Get Free Report)

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.